Rua requires further capital to fund the growth of its business.  The funds raised through the Rights Offer will be used mostly to meet its requirements for working capital and product purchases to support Rua’s growth plans, including international market expansion and product development.  This will strengthen the company's financial position and provide working capital which is required for growth. 

Up to $2m.

Follow the instructions at www.shareoffer.co.nz/rua 

You will need to visit Sharesies.  You will be able to purchase shares through their platform if there is a sufficient shortfall in subscriptions under the Rights Offer.

All investing involves risk—you aren’t guaranteed to make money, and you might lose the money you start with.

We encourage you to do your due diligence, consider the risks involved, and speak to a licensed financial advice provider if you need help deciding whether to take part.

A Renounceable Rights Offer gives current Rua Bioscience shareholders the right to buy additional new shares in the company (New Shares) at a discounted price. If they do not want to purchase additional New Shares, they can give up or “renounce” their right to it, and in fact sell these rights. These rights can be traded or sold on the stock exchange between 11 November and 24 November under the ticker RUARB. You will need to instruct your broker or an NZX Firm to sell your rights, such as Sharesies. 

In summary, if you are already a shareholder, you have a right to buy more New Shares under the Rights Offer or sell the rights to someone else.  

There are different ways to raise capital, but a common way is to issue new shares through a placement or a rights offer.  A rights offer is considered the fairest way as it gives all shareholders the chance to participate on the same terms.

Rua Bioscience currently has approximately 164 million shares and plans to issue another 122 million shares (approximately) through the rights offer and any shortfall placement.  

For every 4 shares you currently own in Rua, you will be allowed to purchase another 3 New Shares for 2.5 cents a share.   This means you will have a “Right” to 3 New Shares for every 4 you own.  

For example, if you own 10,000 shares you will receive 7,500 rights giving you the ability to subscribe for up to 7,500 New Shares for an aggregate subscription price of $187.50.   

Under the example above, you can either: 

1. take up all or some of your Rights (i.e. buy some or all of the 7,500 New Shares up to $187.50); or  

2. take up all of your Rights and apply for Additional New Shares as a part of the Oversubscription Facility (i.e. buy the full 7,500 New Shares for $187.50 and apply for more New Shares at the same price of 2.5 cents per share); or 

3. sell all or some of your Rights on the NZX Main Board (i.e. don’t buy any New Shares but sell your Right to someone else); or 

4. take up some of your Rights, and sell all or some of the remaining balance on the NZX Main Board (i.e. buy some New Shares and sell some of your Rights); or 

5. do nothing with all or some of your Rights. 

By participating, you can: 

- Buy additional shares in Rua Bioscience at a lower price than the current market value. 

- Increase your overall shareholding in the company. 

- Avoid dilution of your existing shareholding (your percentage ownership of RUA won’t decrease if you subscribe in full).